Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Aug 30, 2006 9:01pm
142 Views
Post# 11297863

RE: IPO and other things

RE: IPO and other things Good dialogue on the IPO and other issues. Nice to see the board improving again. MC1500000... I think the whole point of the divisional approach is to unlock the value that isnt currently reflected in the market cap of the parent. Frankly, I think the parts are worth substantially more than the current "whole"... primarilly because of the terrible execution and communication..... and throw in some bad luck... I personally dont think you can argue that the UK division wont be able to do a $50mm IPO simply because of the current PLI market cap... especially because its the whole point of the exercise. The contention is that the UK will pay more for the filter / mad cow story if its in a UK based, UK listed company that is solely focussed on executing a strategy based on its products and technology.... it isnt into funding therapeutics or HMSL projects... its focussed on executing. I frankly think there will be sufficient appetite to pull this off. My contention is that you CAN argue that a well executed divisional IPO will reflect positively on the parent co.. if the parent co retains sufficient ownership....the entire "value" of the combined entity goes up. If PLI retains 70% of an company valued at $50mm plus... then market efficiency should reprice the parent... whereas the market has proven it will not appropriately price the multi divisional parent as it stands right now.... and that leads to all of our frustration. As far as my shares... I have added 150,000 shares over the last 10 days and will add more on any dips. I have no intention of selling anywhere near these levels. I think despite all of the dilution and negativity that has plagued this company... the next few months will be very positive.
Bullboard Posts